Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophages.

Journal of Leukocyte Biology
Seong H ChowThomas Naderer

Abstract

Staphylococcus aureus causes necrotizing pneumonia by secreting toxins such as leukocidins that target front-line immune cells. The mechanism by which leukocidins kill innate immune cells and trigger inflammation during S. aureus lung infection, however, remains unresolved. Here, we explored human-induced pluripotent stem cell-derived macrophages (hiPSC-dMs) to study the interaction of the leukocidins Panton-Valentine leukocidin (PVL) and LukAB with lung macrophages, which are the initial leukocidin targets during S. aureus lung invasion. hiPSC-dMs were susceptible to the leukocidins PVL and LukAB and both leukocidins triggered NLPR3 inflammasome activation resulting in IL-1β secretion. hiPSC-dM cell death after LukAB exposure, however, was only temporarily dependent of NLRP3, although NLRP3 triggered marked cell death after PVL treatment. CRISPR/Cas9-mediated deletion of the PVL receptor, C5aR1, protected hiPSC-dMs from PVL cytotoxicity, despite the expression of other leukocidin receptors, such as CD45. PVL-deficient S. aureus had reduced ability to induce lung IL-1β levels in human C5aR1 knock-in mice. Unexpectedly, inhibiting NLRP3 activity resulted in increased wild-type S. aureus lung burdens. Our findings suggest that NL...Continue Reading

References

Aug 18, 2004·The Medical Journal of Australia·Anton Y Peleg, Wendy J Munckhof
Jan 20, 2007·Science·Maria Labandeira-ReyM Gabriela Bowden
Feb 23, 2010·The Journal of Infectious Diseases·François VandeneschM Gabriela Bowden
Mar 9, 2010·Lancet·Frank R DeLeoHenry F Chambers
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Binh An DiepHenry F Chambers
Aug 19, 2011·The Journal of Infectious Diseases·Scott D KobayashiFrank R Deleo
May 21, 2013·Cell Host & Microbe·András N SpaanJos A G van Strijp
Jun 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ashley L DuMontVictor J Torres
Dec 4, 2014·Nature·Elisa Gomez PerdigueroHans-Reimer Rodewald
Jan 16, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christian M KarstenJörg Köhl
Apr 17, 2015·PLoS Pathogens·Kipyegon KiturAlice Prince
Jun 21, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·András N SpaanJos A G van Strijp
Sep 17, 2015·Nature·Nobuhiko KayagakiVishva M Dixit
Mar 11, 2016·Science Translational Medicine·Taylor S CohenBret R Sellman
Aug 31, 2016·Nature Microbiology·Mary SpeirThomas Naderer
Sep 18, 2016·The Journal of Infectious Diseases·Alice PrinceDane Parker
Sep 23, 2016·Science Translational Medicine·Binh An DiepGerard Lina
Nov 11, 2016·Cell Host & Microbe·Bo ShopsinJagadeesh Bayry
Apr 20, 2017·Nature Reviews. Microbiology·András N SpaanVictor J Torres
Apr 27, 2017·Seminars in Cell & Developmental Biology·E Sachiko Seilie, Juliane Bubeck Wardenburg
Jun 1, 2018·Nature Reviews. Disease Primers·Andie S LeeStephan Harbarth
Aug 25, 2018·Nature Reviews. Immunology·Christopher Z W LeeFlorent Ginhoux

❮ Previous
Next ❯

Citations

Jan 26, 2021·Biochemical Society Transactions·Pratima VermaKausik Chattopadhyay
Feb 8, 2021·Cellular Microbiology·Ye Mon SoeAbderrahman Hachani

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.